Evaluation of the efficacy of atovaquone alone or in combination with azithromycin against acute murine toxoplasmosis

Veterinary Research Communications

Volumn 24, Issue 3, 2000, Pages 169-177

  Moshkani, S K ^a   Dalimi, A ^a  

^a TARBIAT MODARES UNIVERSITY   (Iran)

Author keywords

Atovaquone; Azithromycin; Chemotherapy; Mouse; Toxoplasma gondii

Indexed keywords

ATOVAQUONE; AZITHROMYCIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; DRUG EFFICACY; ERADICATION THERAPY; MOUSE; NONHUMAN; SURVIVAL RATE; TOXOPLASMA GONDII; TOXOPLASMOSIS; VETERINARY MEDICINE;

ANIMALS; ANTI-BACTERIAL AGENTS; ANTIPROTOZOAL AGENTS; ATOVAQUONE; AZITHROMYCIN; DISEASE MODELS, ANIMAL; DRUG SYNERGISM; DRUG THERAPY, COMBINATION; FEMALE; MICE; NAPHTHOQUINONES; RANDOM ALLOCATION; TOXOPLASMA; TOXOPLASMOSIS, ANIMAL;

ANIMALIA; MURINAE; TOXOPLASMA GONDII;

EID: 0033995749     PISSN: 01657380     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1006404314523     Document Type: Article

References (17)

1. Araujo, F.G., Guptil, D.R. and Remington, J.S., 1988. Azithromycin, a macrolide antibiotic with potent activity against Toxoplasma gondii. Antimicrobial Agents and Chemotherapy, 32, 755-757
2. Araujo, F.G., Huskinson, J. and Remington, J.S., 1991a. Remarkable in vitro and in vivo activities of the hydroxynaphthoquinone 566C80 against tachyzoites and tissue cysts of Toxoplasma gondii. Antimicrobial Agents and Chemotherapy, 35, 293-299
3. Araujo, F.G., Shepard, R.M. and Remington, J.S., 1991b. In vivo activity of the macrolide antibiotic azithromycin, roxithromycin and spiramycin against Toxoplasma gondii. European Journal of Clinical Microbiology and Infectious Disease, 10, 519-524
4. Araujo, F.G., Huskinson, J., Gutteridge, W.E. and Remington, J.S., 1992. In vivo and in vitro activities of the hydroxynaphthoquinone 566C80 against the cyst form of Toxoplasma gondii. Antimicrobial Agents and Chemotherapy, 36, 326-330
5. Araujo, F.G., Lin, T. and Remington, J.S., 1993. The activity of atovaquone (566C80) in murine toxoplasmosis is augmented when used in combination with pyrimethamine or sulfadiazine. Journal of Infectious Diseases, 167, 494-497
6. Araujo, F.G., Slifer, T. and Remington, J.S., 1994. Rifabutin is active in murine models of toxoplasmosis. Antimicrobial Agents and Chemotherapy, 38, 570-575
7. Chamberland, S., Kirst, H.A. and Current, W.L., 1991. Comparative activity of macrolides against Toxoplasma gondii demonstrating utility of an in vitro microassay. Antimicrobial Agents and Chemotherapy, 35, 903-909
8. Chang, H.R., Rudareanu, F.C. and Pechere, J.C., 1988. Activity of A-56268(TE-031), a new macrolide, against Toxoplasma gondii in mice. Journal of Antimicrobial Chemotherapy, 22, 359-361
9. Derouin, F., Almadany, R., Chau, F., Rouveix, B. and Pocidalo, J.J., 1992. Synergistic activity of azithromycin and pyrimethamine or sulfadiazine in acute experimental toxoplasmosis. Antimicrobial Agents and Chemotherapy, 36, 997-1001
10. Farthing, C., Rendel, M., Currie, B. and Seidlin, M., 1992. Azithromycin for cerebral toxoplasmosis. The Lancet, 339, 437-438
11. Godofsky, E.W., 1994. Treatment of presumed cerebral toxoplasmosis with azithromycin. New England Journal of Medicine, 330, 575-576
12. Huskinson-Mark, J., Araujo, F.G. and Remington, J.S., 1991. Evaluation of the effect of drugs on the cyst form of Toxoplasma gondii. Journal of Infectious Diseases, 164, 170-177
13. Kovacs, J.A. and the NIAID-Clinical Center Intramural AIDS program, 1992. Efficacy of atovaquone in treatment of toxoplasmosis in patients with AIDS. The Lancet, 340, 637-638
14. Lindsay, D.S., Blagburn, B.L., Hall, J.E. and Tidwell, R.R., 1991. Activity of pentamidine and pentamidine analogs against Toxoplasma gondii in cell cultures. Antimicrobial Agents and Chemotherapy, 35, 1914-1916
15. Lopez, J.S., Smet, M.D., Masure, H., Muller, B.U., Pizzo, P.A. and Nussenblatt, R.B., 1991. Orally administered 566C80 for treatment of ocular toxoplasmosis in a patient with acquired immunodeficiency syndrome. American Journal of Ophthalmology, 113, 331-333
16. Romand, S., Pudney, M. and Derouin, F., 1993. In vitro and in vivo activity of the hydroxynaphthoquinone atovaquone alone or combined with pyrimethamine, sulfadiazine, clarithromycin, or minocycline against Toxoplasma gondii. Antimicrobial Agents and Chemotherapy, 37, 2371-2378
17. Romand, S., Bruna, C.D., Farinotti, R. and Derouin, F., 1996. In vitro and in vivo effects of rifabutine alone or combined with atovaquone against Toxoplasma gondii. Antimicrobial Agents and Chemotherapy, 40, 2015-2020